Trial comparisons

Response

The first 2 of this page's 20 results. GET /api/comparisons/v1?page=58

{
  "data": {
    "total": 85013,
    "results": [
      {
        "id": "NCT01035255-c1d0a2ad",
        "title": "LCZ696 vs Enalapril: Number of Patients - All-cause Mortality",
        "summary": "711 of 4187 against 835 of 4212; risk difference -2.8 points, 95% interval -4.5 to -1.2; NCT01035255, This Study Will Evaluate the Efficacy and Safety of LCZ696 Compared to Enalapril on Morbidity and Mortality of Patients With Chronic Heart Failure",
        "record": "/library/comparisons/NCT01035255-c1d0a2ad",
        "nct_id": "NCT01035255",
        "kind": "outcome",
        "participants": 8399,
        "risk_difference": {
          "value": -0.02843179415506461,
          "lower": -0.04498840150213024,
          "upper": -0.011859260840896425
        },
        "group_1": "711 of 4,187",
        "group_2": "835 of 4,212",
        "difference": "-2.8 points",
        "interval": "-4.5 to -1.2",
        "trial_title": "This Study Will Evaluate the Efficacy and Safety of LCZ696 Compared to Enalapril on Morbidity and Mortality of Patients With Chronic Heart Failure"
      },
      {
        "id": "NCT05640648-51e37c9d",
        "title": "Standard Implementation Strategy Period vs Enhanced Contact Investigation Intervention Period: Number of Contacts Initiating TB Preventative Therapy",
        "summary": "122 of 2829 against 264 of 5560; risk difference -0.4 points, 95% interval -1.3 to 0.5; NCT05640648, Human-centered Design and Communities of Practice to Improve Home-based Tuberculosis Contact Investigation in Uganda",
        "record": "/library/comparisons/NCT05640648-51e37c9d",
        "nct_id": "NCT05640648",
        "kind": "outcome",
        "participants": 8389,
        "risk_difference": {
          "value": -0.004357235314611511,
          "lower": -0.013431552495882291,
          "upper": 0.005335548488621923
        },
        "group_1": "122 of 2,829",
        "group_2": "264 of 5,560",
        "difference": "-0.4 points",
        "interval": "-1.3 to 0.5",
        "trial_title": "Human-centered Design and Communities of Practice to Improve Home-based Tuberculosis Contact Investigation in Uganda"
      }
    ],
    "no_events": 33758,
    "columns": [
      {
        "key": "title",
        "label": "Comparison"
      },
      {
        "key": "group_1",
        "label": "With the outcome",
        "under": "group_2"
      },
      {
        "key": "difference",
        "label": "Risk difference, 95% interval",
        "under": "interval"
      },
      {
        "key": "participants",
        "label": "Participants"
      },
      {
        "key": "nct_id",
        "label": "Trial",
        "under": "trial_title"
      }
    ],
    "order": "Most participants first",
    "kinds": {
      "all": 85013,
      "outcome": 33568,
      "serious-adverse-events": 31897,
      "deaths": 19548
    }
  },
  "release": "trial-comparisons-2026-03-23-0.1.0",
  "terms": [
    {
      "source": "ClinicalTrials.gov's posted results, through CTTI's AACT",
      "license": "ClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299",
      "notice": "ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions. The measures are ConductScience's calculation from them.",
      "short": "Freely available. Acknowledgement requested"
    },
    {
      "source": "ClinicalTrials.gov",
      "license": "none stated",
      "notice": "ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions. The measures are ConductScience's calculation from them.",
      "short": "None stated"
    }
  ],
  "next": "/api/comparisons/v1?page=59",
  "request_id": "q0ecgApcbH3OLRAD"
}